Showing results (41-50 of 245) with videos related to

Sort By:
Pageof 25
Cancers|October 28, 2023
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular CarcinomaAloña Agirre-Lizaso, Maider Huici-Izagirre, Josu Urretabizkaia-Garmendia, et al.
Nature Reviews. Gastroenterology & Hepatology|June 6, 2019
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseasesLuca Fabris, Romina Fiorotto, Carlo Spirli, et al.
Journal of Hepatology|November 28, 2017
Clinical management of polycystic liver diseaseRené M M van Aerts, Liyanne F M van de Laarschot, Jesus M Banales, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactionsAlessandra Zingoni, Thierry Sornasse, Benjamin G Cocks, et al.
Nature Reviews. Gastroenterology & Hepatology|October 1, 2014
Polycystic liver diseases: advanced insights into the molecular mechanismsMaria J Perugorria, Tatyana V Masyuk, Jose J Marin, et al.
Frontiers in Immunology|April 18, 2018
NKG2D and Its Ligands: "One for All, All for One"Alessandra Zingoni, Rosa Molfetta, Cinzia Fionda, et al.
The Journal of General Virology|December 16, 2006
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicityCristina Cerboni, Francesca Neri, Nicoletta Casartelli, et al.
Current Drug Targets|August 26, 2015
Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for TherapyOihane Erice, Maite Merino-Azpitarte, Ander Arbelaiz, et al.
Pageof 25